2. Summary of Significant Accounting Policies (Details Narrative) - USD ($) |
3 Months Ended | 10 Months Ended | |
---|---|---|---|
Mar. 31, 2020 |
Mar. 31, 2019 |
Nov. 13, 2019 |
|
Cash in excess of FDIC | $ 5,129,790 | ||
Warrants [Member] | |||
Antidilutive shares | 3,986,630 | 3,674,130 | |
Options [Member] | |||
Antidilutive shares | 1,939,500 | 675,000 | |
Convertible Debt Securities [Member] | |||
Antidilutive shares | 200,000 | ||
Over-Allotment Option [Member] | Underwriter [Member] | |||
Stock issued new, shares | 318,750 | ||
I P O [Member] | |||
Stock issued new, shares | 2,125,000 | ||
Stock price | $ 4.00 |
X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation. No definition available.
|
X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|